Patent ID: 8765395

Claim:
A method for detecting the presence or absence of Methicillin Resistant Staphylococcus Aureus (“MRSA”) in a first generation biological test sample, the method comprising the steps of: a) providing a test mixture containing a source of powdered coagulase substrates, and an amount of cefoxitin effective to kill any Methicillin Susceptible Staphylococcus Aureus (“MSSA”) in the test sample; b) hydrating the test mixture in a container; c) admixing said first generation biological test sample with the hydrated test mixture in the container; d) incubating the admixture of the first generation biological test sample and the test mixture in the container at temperatures in the range of about 20° C. to about 42° C.; and e) detecting the presence or absence of MRSA in the admixture of the test sample and the hydrated test mixture based on the presence or absence of clotting in the admixture.